CN EN
news

Wuxi, July 6, 2023 – Supporting clients in the high-growth in vitro drug discovery industry, BioDuro-Sundia Discovery Biology Department is proud to announce our enhanced formats and selection of biochemical assays, cell-based assays, and other emerging assay technologies.

This July, our R&D Center in Jiangsu, China launched as BioDuro-Sundia's most advanced radio-lab to date. The Jiangsu radio-lab's opening re-establishes our legacy operations in radiometric assays and supplements our broad array of illuminating assay detection formats, such as fluorescence and luminescence. We carry forward knowledge gained from experience. 

BioDuro-Sundia Discovery Biology Capabilities in Jiangsu site including:  

- Epigenetics studies related METTL3/14, P300&CBP, G9a&GLP and PRMT5 inhibitor screening and MOA verification assay 

- GPCR receptor-ligand binding assay of A2a 

- Receptor-ligand binding 

- Kinase reaction 

- Metabolite production analysis experiments using isotopes 

- Other enzymatic, GPCR, and epigenetics related assays  

About BioDuro-Sundia  

BioDuro-Sundia, an Advent International portfolio company, is a trusted, leading contract research development, and manufacturing organization (CRDMO) for over 27 years. We provide our biotech and pharmaceutical partners with fully integrated services to support their efforts from target identification through to commercial drug product manufacturing. The company is based in the US and China with more than 3,000 employees and 10 global sites across 6 cities.  

Core expertise includes small and large molecule discovery, development and scale up, support for IND submission, and unique technology platforms such as bioavailability enhancement of insoluble compounds. The one-stop-shop operation helps biotech and pharma partners across the globe to significantly accelerate discovery and de-risk development to create higher value outcomes. We adhere to one global highest standard of compliance and business operation code. Our science-driven, customer-oriented, people-focused culture enables us to provide top-tier integrated, fast, and flexible tailored services to our customers, to meet their unique needs and accelerate development timelines. For more information, please visit www.bioduro-sundia.com

Large Molecule Bioanalysis Services
BioDuro-Sundia’s large molecule bioanalysis DMPK/ADME platform provides representative research services to a variety of molecular modalities including mAbs, ADC, oligonucleotides, large or small molecule biomarkers or metabolites, proteins and peptides.
View more
We use necessary cookies to ensure our website functions properly and to keep it secure. These necessary cookies must be enabled. By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. You can personalize or withdraw your consent at any moment by clicking on the link "Cookies Settings". For more information on how we use cookies, including the total lifespan of cookies and the identity of third parties intervening on our website, please consult the Privacy Notice available in the site footer.
Accept all